Cardiovascular outcomes among participants with diabetes in the recent large statin trials.
PURPOSE OF REVIEW: Despite their increased cardiovascular risk and its continuous relationship with cholesterol, until recently only diabetic patients with marked dyslipidaemia were routinely offered lipid-lowering therapy. The secondary prevention statin trials led to more widespread cholesterol l...
Main Authors: | , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2004
|